Market revenue in 2023 | USD 31.4 million |
Market revenue in 2030 | USD 53.4 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Anti-bacterial |
Fastest growing segment | Anti-fungal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-bacterial, Anti-fungal, Corticosteroids, Others (Acaricidals, Cyclosporins) |
Key market players worldwide | Zoetis, Elanco Animal Health Inc, Dechra Pharmaceuticals, Merck & Co Inc, Vetoquinol SA, Virbac SA, CEVA Inc, Penn Veterinary Supply Inc, Vedco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal ear infection treatment market will help companies and investors design strategic landscapes.
Anti-bacterial was the largest segment with a revenue share of 43.95% in 2023. Horizon Databook has segmented the Canada companion animal ear infection treatment market based on anti-bacterial, anti-fungal, corticosteroids, others (acaricidals, cyclosporins) covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in pet ownership and growth in investments by pet owners in veterinary treatments are likely to accelerate Canada’s veterinary medicine & product demand. According to the Canadian Animal Health Institute, in 2020, around 58% of Canadians owned at least one pet.
From 2018 to 2020, the Canadian dog population increased from 7.6 million to 7.7 million. Key players are contributing to market growth through various strategies, including regional expansions, new product launches, and partnerships & collaborations.
In February 2020, Bayer (Elanco) launched Neptra ear solution against ear infection in the UK market, which had increased its geographic footfall. As Elanco offers their product across the globe including Canada, thus contributes to Canada’s companion animal ear infection treatment market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada companion animal ear infection treatment market , including forecasts for subscribers. This country databook contains high-level insights into Canada companion animal ear infection treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account